DK1603564T3 - Anvendelse af pyridin-2-yl-methylaminderivater til fremstilling af et medikament til behandling af kroniske neuropatologiske eller psykogene smertesymptomer - Google Patents
Anvendelse af pyridin-2-yl-methylaminderivater til fremstilling af et medikament til behandling af kroniske neuropatologiske eller psykogene smertesymptomerInfo
- Publication number
- DK1603564T3 DK1603564T3 DK04720637T DK04720637T DK1603564T3 DK 1603564 T3 DK1603564 T3 DK 1603564T3 DK 04720637 T DK04720637 T DK 04720637T DK 04720637 T DK04720637 T DK 04720637T DK 1603564 T3 DK1603564 T3 DK 1603564T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyridin
- treatment
- analgesic
- alkyl
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0303099A FR2852244B1 (fr) | 2003-03-13 | 2003-03-13 | Utilisation de derives de pyridin-2-yl-methylamine pour la preparation d'un medicament destine au traitement des symptomes de la douleur chronique d'origine neuropathique ou psychogene |
PCT/FR2004/000630 WO2004083171A2 (fr) | 2003-03-13 | 2004-03-15 | Utilisation de derives de pyridin-2-yl-methylamine pour le traitement des symptomes de la douleur chronique neuropathique ou psychogene |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1603564T3 true DK1603564T3 (da) | 2007-10-01 |
Family
ID=32893267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04720637T DK1603564T3 (da) | 2003-03-13 | 2004-03-15 | Anvendelse af pyridin-2-yl-methylaminderivater til fremstilling af et medikament til behandling af kroniske neuropatologiske eller psykogene smertesymptomer |
Country Status (25)
Country | Link |
---|---|
US (1) | US8609694B2 (zh) |
EP (1) | EP1603564B1 (zh) |
JP (1) | JP4684994B2 (zh) |
KR (1) | KR101100002B1 (zh) |
CN (1) | CN1761467B (zh) |
AT (1) | ATE366111T1 (zh) |
AU (1) | AU2004222051B2 (zh) |
BR (1) | BRPI0408293A (zh) |
CA (1) | CA2518591C (zh) |
CY (1) | CY1106900T1 (zh) |
DE (1) | DE602004007364T2 (zh) |
DK (1) | DK1603564T3 (zh) |
ES (1) | ES2289494T3 (zh) |
FR (1) | FR2852244B1 (zh) |
HK (1) | HK1079120A1 (zh) |
IL (1) | IL170743A (zh) |
MX (1) | MXPA05009782A (zh) |
NO (1) | NO334997B1 (zh) |
NZ (1) | NZ542461A (zh) |
PL (1) | PL1603564T3 (zh) |
PT (1) | PT1603564E (zh) |
RU (1) | RU2359674C2 (zh) |
UA (1) | UA81023C2 (zh) |
WO (1) | WO2004083171A2 (zh) |
ZA (1) | ZA200507634B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071778B2 (en) | 2006-07-27 | 2011-12-06 | Bristol-Myers Squibb Company | Substituted heterocyclic ethers and their use in CNS disorders |
WO2009096941A1 (en) * | 2008-01-28 | 2009-08-06 | Bristol-Myers Squibb Company | Substituted heterocyclic ethers and their use in cns disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020346A (en) | 1995-01-12 | 2000-02-01 | Glaxo Wellcome Inc. | Piperidine derivatives having tachykinin antagonist activity |
FR2755967B1 (fr) * | 1996-11-21 | 1999-01-29 | Pf Medicament | Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments |
FR2784378B1 (fr) * | 1998-10-09 | 2000-12-29 | Pf Medicament | Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
FR2840900B1 (fr) | 2002-06-18 | 2005-02-25 | Pf Medicament | Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
-
2003
- 2003-03-13 FR FR0303099A patent/FR2852244B1/fr not_active Expired - Fee Related
-
2004
- 2004-03-15 DE DE602004007364T patent/DE602004007364T2/de not_active Expired - Lifetime
- 2004-03-15 ES ES04720637T patent/ES2289494T3/es not_active Expired - Lifetime
- 2004-03-15 CN CN2004800068827A patent/CN1761467B/zh not_active Expired - Lifetime
- 2004-03-15 DK DK04720637T patent/DK1603564T3/da active
- 2004-03-15 US US10/549,076 patent/US8609694B2/en active Active
- 2004-03-15 PT PT04720637T patent/PT1603564E/pt unknown
- 2004-03-15 PL PL04720637T patent/PL1603564T3/pl unknown
- 2004-03-15 JP JP2006505728A patent/JP4684994B2/ja not_active Expired - Lifetime
- 2004-03-15 BR BRPI0408293-1A patent/BRPI0408293A/pt not_active Application Discontinuation
- 2004-03-15 KR KR1020057017151A patent/KR101100002B1/ko active IP Right Grant
- 2004-03-15 MX MXPA05009782A patent/MXPA05009782A/es active IP Right Grant
- 2004-03-15 AU AU2004222051A patent/AU2004222051B2/en not_active Ceased
- 2004-03-15 AT AT04720637T patent/ATE366111T1/de active
- 2004-03-15 UA UAA200509594A patent/UA81023C2/uk unknown
- 2004-03-15 RU RU2005131615/15A patent/RU2359674C2/ru not_active IP Right Cessation
- 2004-03-15 CA CA2518591A patent/CA2518591C/fr not_active Expired - Lifetime
- 2004-03-15 EP EP04720637A patent/EP1603564B1/fr not_active Expired - Lifetime
- 2004-03-15 WO PCT/FR2004/000630 patent/WO2004083171A2/fr active IP Right Grant
- 2004-03-15 NZ NZ542461A patent/NZ542461A/en not_active IP Right Cessation
-
2005
- 2005-09-08 IL IL170743A patent/IL170743A/en not_active IP Right Cessation
- 2005-09-21 ZA ZA200507634A patent/ZA200507634B/en unknown
- 2005-10-11 NO NO20054673A patent/NO334997B1/no not_active IP Right Cessation
-
2006
- 2006-01-24 HK HK06101061A patent/HK1079120A1/xx not_active IP Right Cessation
-
2007
- 2007-10-02 CY CY20071101255T patent/CY1106900T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Westerink et al. | Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum | |
RU2334747C1 (ru) | ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ | |
US20210023043A1 (en) | Methods of Treating Hyperalgesia | |
US9789117B2 (en) | Use of sigma ligands in diabetes type-2 associated pain | |
AU2007221135A1 (en) | Methods for regulating neurotransmitter systems by inducing counteradaptations | |
MA28706B1 (fr) | Antagoniste des recepteurs du glucagon, preparation et utilisations therapeutiques | |
CR9808A (es) | Procedimiento de tratamiento de la arterosclerosis, dispilidemias y afecciones relacionadas y composiciones farmaceuticas | |
ES2955490T3 (es) | Métodos y composiciones para potenciar la acción de los analgésicos opioides mediante el uso de alcaloides de la iboga | |
CN107417620A (zh) | σ配体在阿片类药物诱导的痛觉过敏中的应用 | |
WO2010097334A1 (de) | Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids | |
TWI629984B (zh) | σ配體在與間質性膀胱炎/膀胱疼痛綜合徵(IC/BPS)相關的疼痛的預防和治療中的應用 | |
US20080045610A1 (en) | Methods for regulating neurotransmitter systems by inducing counteradaptations | |
WO2006049312A1 (ja) | 神経因性疼痛治療剤 | |
KR20110021823A (ko) | 진통 내성 억제제 | |
KR20060121178A (ko) | 일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제 | |
Horita et al. | Effects of TRH on the central nervous system of the rabbit | |
NO20054673L (no) | Anvendelse av pyridin-2yl-metylaminderivater for fremstilling av et medikament beregnet for behandling av nevropatiske og psykogene kroniske smertesymptomer | |
US20070259945A1 (en) | Method for treating pain | |
Lauretti | Highlights in opioid agonists and antagonists | |
MX2022004610A (es) | Uso de derivado de fenilquinolinona o derivado flavonoide para tratamiento del dolor neuropático. | |
ZA200702379B (en) | Piperidine derivative or pharmaceutically acceptable salt thereof | |
WO2006060190A2 (en) | Imidazole derivatives | |
US20210228555A1 (en) | Method of treatment with tradipitant | |
Kim | The Effect of Intraarticular Morphine and Clonidine on Postoperative Analgesia after Knee Surgery. | |
Ashton et al. | Neuropharmacological profile of R 18 503-induced wet-shake behavior in the rat: Noradrenergic and opiate components |